Observational Study of Early Metabolic and Vascular Changes in Obesity
NCT00482924 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1500
Last updated 2021-09-22
Summary
To work against the increasing burden of obesity, the STYJOBS / EDECTA (STYrian Juvenile OBesity Study / Early DetECtion of Atherosclerosis) project was started at the Medical University of Graz in 2003. STYJOBS / EDECTA is a prospective, observational study to improve the understanding of atherosclerosis, cardiovascular risk, immune mediated low grade Inflammation, metabolic changes, and general disease propensity in obesity. The investigation of the "non-biased" early phase is strongly focused.
Based on this information, new and effective strategies for preclinical diagnostics and early intervention are of main interest. We seek a better understanding of critical lipid profiles, chronic immune-mediated inflammation, disturbed adipokine balance, critical adipose tissue topography, addiction like behaviour, genetics/epigenetics, early vascular pathology, and fatty liver disease. Interventional branches of study tested a holistic strategy comprehending sports, and lifestyle modification for efficiency. The investigative spectrum of STYJOBS / EDECTA comprehends also non-obese body weight extremes i.e. underweight/anorectic people.
Conditions
- Obesity
- Atherosclerosis
- Inflammation
- Adiponectin Deficiency
- Fatty Liver
Interventions
- OTHER
-
Lifestyle intervention
Regular sports and dietary advices. Controlled by analysis of laboratory parameters, BMI change and performance diagnostics. No drugs included so far.
Sponsors & Collaborators
-
Zukunftsfonds Steiermark
collaborator OTHER -
Bundesministerium für Gesundheit, Familie und Jugend
collaborator UNKNOWN -
Steiermärkische Landesregierung
collaborator UNKNOWN -
Graz University of Technology
collaborator OTHER -
University of Graz
collaborator OTHER -
Paracelsus Medical University
collaborator OTHER -
Technical University of Munich
collaborator OTHER -
Medical University of Graz
lead OTHER
Principal Investigators
-
Harald Mangge, Prof., MD · Medical University of Graz, Austria
Eligibility
- Min Age
- 3 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2003-01-31
- Primary Completion
- 2022-12-31
- Completion
- 2022-12-31
Countries
- Austria
Study Locations
More Related Trials
-
Sympathetic Activity in Individuals With the Metabolic Syndrome: Benefits of Lifestyle Interventions
NCT00163943 ·Status: UNKNOWN ·Phase: NA
-
Study of How Exercise or Weight Loss Effects Metabolic Syndrome
NCT00292994 ·Status: UNKNOWN ·Phase: NA
-
Effect of a Low Glycemic Index on Metabolic Syndrome
NCT02356952 ·Status: COMPLETED ·Phase: NA
-
Frequency of Metabolic Syndrome in Down Syndrome Patients
NCT00864461 ·Status: COMPLETED
-
Metabolic Flexibility to Predict Lifestyle Interventions Outcomes
NCT06329349 ·Status: RECRUITING ·Phase: NA
-
Diet and Physical Activity on NAFLD and Erytrocyte Membrane Lipid Profile.
NCT02347696 ·Status: UNKNOWN ·Phase: NA
-
MOVING - MOtiVation, INtervention and Vascular chanGe
NCT01919632 ·Status: COMPLETED ·Phase: NA
-
Molecular Landscape of Complex Lifestyle Modification
NCT06954298 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Exercise and Technology to Reduce Risk in a Rural Population With Metabolic Syndrome
NCT01944124 ·Status: COMPLETED ·Phase: NA
-
Impact of Interventions With a Diet and Exercise on the Cardio-metabolic Status in Multi-risk Population
NCT03701425 ·Status: UNKNOWN ·Phase: NA
-
Fertility and Cardiovascular Risk in Men With Metabolic Syndrome
NCT03977064 ·Status: UNKNOWN ·Phase: NA
-
Effect of an Early Time Restricted Eating Mediterranean Diet Compared to Naltrexone/Bupropion on Liver Fibrosis in People With Cardiometabolic Risk Factors in a Hospital Outpatient Clinic (MEDFAST-study)
NCT06845345 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Multi-faceted Evaluations Following Weight Reduction in Subjects With Metabolic Syndrome
NCT01065753 ·Status: COMPLETED ·Phase: NA
-
Mechanisms of Exercise Resistance in Metabolic Disease
NCT03945435 ·Status: COMPLETED
-
A Tailored, Optimised, and Person-centred Programme to Promote Lifestyle Modification in People With Metabolic Syndrome
NCT06793930 ·Status: RECRUITING ·Phase: NA
-
Assessment of Progranulin and FAM19A5 Protein Blood Levels in Metabolic Syndrome
NCT04451616 ·Status: UNKNOWN
-
Mhealth Social Support for People at Risk of Metabolic Syndrome
NCT06169943 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Lifestyle and Its Association With Maintaining Health
NCT07309484 ·Status: ENROLLING_BY_INVITATION
-
Effect of MetS* on Cognitive Performance and Physical Activity (Metabolic Syndrome)
NCT05702437 ·Status: RECRUITING
-
Impact of a Lifestyle Program on Quality of Life in Pemphigus Patients
NCT06901427 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Regional Observation of the Metabolic Syndrome
NCT00874952 ·Status: COMPLETED
-
Effect of a Treatment of Lifestyle Changes on the Prevalence of Metabolic Syndrome and Body Weight in Mexican Women
NCT02247635 ·Status: COMPLETED ·Phase: NA
-
Effect of Eplerenone on Endothelial Function in Metabolic Syndrome
NCT01319344 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Understand the Distribution of Obesity Classes and Obesity Related Diseases in People With Obesity Across Countries in Czech Republic, Hungary and Poland
NCT05795166 ·Status: COMPLETED
-
Effectiveness of a Lifestyle Intervention on Metabolic Syndrome.
NCT03416439 ·Status: COMPLETED ·Phase: PHASE3